62P A Multi-Center Real-World Study of the Efficacy and Safety of PARP Inhibitors in Patients with Ovarian Cancer in Spain
ESMO Open(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined